Antiparasitic Drugs and Cancer Treatment
Ivermectin and mebendazole aren't just antiparasitics.
New science shows they may disrupt cancer cell metabolism and glioma
growth. When I was healing from brain cancer,
I dove into the science behind cancer
metabolism, and I found something shocking.
Old antiparasitic drugs like ivermectin and mebendazole
have powerful anticancer properties. Here's what they do.
Ivermectin blocks tumor cells from generating energy through
oxidative phosphorylation. It inhibits cancer stem
cells. It also disrupts glucose uptake, starving tumors
at the source. Mebendazole, on the other hand, interferes with
microtubule formation in glioma cells, induces apoptosis,
cell death, in hard-to-kill cancer cells, crosses the blood-brain
barrier, making it a rare and powerful force against brain tumors.
These aren't fringe ideas. They're backed by emerging science
and being used
in terrain-based cancer protocols.
And when combined with fasting, oxygen therapy, and targeted
nutrition, they help flip the metabolic switch
and support the body's
natural healing power. This is how I personally fought back.
End of transcript · 162 words